Catalyst
Slingshot members are tracking this event:
FDA rejects Acacia Pharma's amisulpride for postoperative nausea and vomiting
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 08, 2018
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Amisulpride, Postoperative Nausea, Vomiting, Cr845